On September 3, 2024, the European Union’s Court of Justice (ECJ) issued its highly anticipated judgment in the Illumina/Grail case (C-611/22 P and C-625/22 P) concerning the European Commission’s (EC’s) power to review...more
The European Union’s Court of Justice (ECJ) has rendered its two long-awaited judgments in the European Commission’s (EC’s) perindopril case. The 27 June 2024 judgments concern:
- The EC’s appeal of the General Court’s...more
7/29/2024
/ Antitrust Provisions ,
EU ,
European Commission ,
European Court of Justice (ECJ) ,
License Agreements ,
Licensees ,
Life Sciences ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Treaty on the Functioning of the European Union (TFEU)
In her opinion issued on June 4, 2020, Advocate General (AG) Juliane Kokott recommended that the European Court of Justice (ECJ) dismiss in its entirety the appeal by Lundbeck A/S and Lundbeck Ltd against the General Court’s...more
6/9/2020
/ Advocate General ,
Cartels ,
Competition ,
EU ,
European Court of Justice (ECJ) ,
Generic Drugs ,
Intellectual Property Protection ,
Manufacturers ,
Marketing ,
Patents ,
Pay-For-Delay ,
Pharmaceutical Industry